A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer

Clinical trial NCT01095848 · COMPLETED

Trial details

NCT number: NCT01095848
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Neoplasms Breast Neoplasms Prostatic Neoplasms

Start date: 2010-03-01
Primary completion: 2011-04-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.